From PitchBook
DNA sequencing startup Oxford Nanopore Technologies is planning to list on the London Stock Exchange in the second half of the year. The UK-based company is expected to be valued at between £4 billion and £7 billion, the Financial Times reported. Oxford Nanopore has received more than £600 million in funding to date.
SIGN UP